INS and metabolic syndrome: Hepatic insulin resistance results in the elevation of hepatic glucose production and triglyceride (TG) accumulation by impairing insulin-mediated inhibition of gluconeogenesis and regulating insulin-mediated TG metabolism, respectively, which contributes to hyperglycemia and dyslipidemia [1].